Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant .

Background: () is an important cause of nosocomial infections, and contributes to high morbidity and mortality, especially in intensive care units. is considered a 'critical' category bacterial pathogen by the World Health Organization to encourage an urgent need for research and development of new antibiotics against its infections.

Aim: To investigate the effectiveness of baicalin combined with tobramycin therapy as a potential treatment method for carbapenem-resistant (CRPA) infections.